Literature DB >> 21098043

Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.

Erica S Levitt1, Lauren C Purington, John R Traynor.   

Abstract

Organization of G protein-coupled receptors and cognate signaling partners at the plasma membrane has been proposed to occur via multiple mechanisms, including membrane microdomains, receptor oligomerization, and protein scaffolding. Here, we investigate the organization of six types of Gi/o-coupled receptors endogenously expressed in SH-SY5Y cells. The most abundant receptor in these cells was the μ-opioid receptor (MOR), the activation of which occluded acute inhibition of adenylyl cyclase (AC) by agonists to δ-opioid (DOR), nociceptin/orphanin FQ peptide (NOPr), α2-adrenergic (α2AR), cannabinoid 1, and serotonin 1A receptors. We further demonstrate that all receptor pairs share a common pool of AC. The MOR agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO) also occluded the ability of DOR agonist to stimulate G proteins. However, at lower agonist concentrations and at shorter incubation times when G proteins were not limiting, the relationship between MOR and DOR agonists was additive. The additive relationship was confirmed by isobolographic analysis. Long-term coadministration of MOR and DOR agonists caused cAMP overshoot that was not additive, suggesting that sensitization of AC mediated by these two receptors occurs by a common pathway. Furthermore, heterologous inhibition of AC by agonists to DOR, NOPr, and α2AR reduced the expression of cAMP overshoot in DAMGO-dependent cells. However, this cross-talk did not lead to heterologous tolerance. These results indicate that multiple receptors could be tethered into complexes with cognate signaling proteins and that access to shared AC by multiple receptor types may provide a means to prevent opioid withdrawal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098043      PMCID: PMC3061372          DOI: 10.1124/mol.110.064816

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

2.  Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.

Authors:  A Alt; M J Clark; J H Woods; J R Traynor
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2.

Authors:  M A Davare; V Avdonin; D D Hall; E M Peden; A Burette; R J Weinberg; M C Horne; T Hoshi; J W Hell
Journal:  Science       Date:  2001-07-06       Impact factor: 47.728

4.  An overview of drug combination analysis with isobolograms.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2006-05-02       Impact factor: 4.030

5.  Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains.

Authors:  Aude Saulière; Gérald Gaibelet; Claire Millot; Serge Mazères; André Lopez; Laurence Salomé
Journal:  FEBS Lett       Date:  2006-09-05       Impact factor: 4.124

6.  Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies.

Authors:  Venetia Zachariou; Rongjian Liu; Quincey LaPlant; Guanghua Xiao; William Renthal; Guy C Chan; Daniel R Storm; George Aghajanian; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2008-01-28       Impact factor: 13.382

7.  Orphanin FQ/nociceptin inhibits morphine withdrawal.

Authors:  J Kotlińska; P Suder; A Legowska; K Rolka; J Silberring
Journal:  Life Sci       Date:  2000-01-14       Impact factor: 5.037

8.  Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.

Authors:  A Alt; I J McFadyen; C D Fan; J H Woods; J R Traynor
Journal:  J Pharmacol Exp Ther       Date:  2001-07       Impact factor: 4.030

Review 9.  Lipid raft microdomains and neurotransmitter signalling.

Authors:  John A Allen; Robyn A Halverson-Tamboli; Mark M Rasenick
Journal:  Nat Rev Neurosci       Date:  2006-12-29       Impact factor: 34.870

10.  Local opiate withdrawal in locus coeruleus neurons in vitro.

Authors:  A Ivanov; G Aston-Jones
Journal:  J Neurophysiol       Date:  2001-06       Impact factor: 2.714

View more
  19 in total

1.  Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design.

Authors:  Marcin Maziarz; Jong-Chan Park; Anthony Leyme; Arthur Marivin; Alberto Garcia-Lopez; Prachi P Patel; Mikel Garcia-Marcos
Journal:  Cell       Date:  2020-07-06       Impact factor: 41.582

2.  Heterologous regulation of Mu-opioid (MOP) receptor mobility in the membrane of SH-SY5Y cells.

Authors:  Kévin Carayon; Lionel Moulédous; Anne Combedazou; Serge Mazères; Evert Haanappel; Laurence Salomé; Catherine Mollereau
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

3.  Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.

Authors:  Qin Wang; John R Traynor
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

Review 4.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

5.  Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization.

Authors:  Tarja T Leskelä; Jarkko J Lackman; Miia M Vierimaa; Hiroyuki Kobayashi; Michel Bouvier; Ulla E Petäjä-Repo
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

6.  Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.

Authors:  Nunzio Vicario; Lorella Pasquinucci; Federica M Spitale; Santina Chiechio; Rita Turnaturi; Filippo Caraci; Daniele Tibullo; Roberto Avola; Rosario Gulino; Rosalba Parenti; Carmela Parenti
Journal:  Mol Neurobiol       Date:  2019-04-28       Impact factor: 5.590

7.  5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19.

Authors:  Qin Wang; Akiko Terauchi; Christopher H Yee; Hisashi Umemori; John R Traynor
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

8.  Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.

Authors:  Divya Ramesh; Gracious R Ross; Joel E Schlosburg; Robert A Owens; Rehab A Abdullah; Steven G Kinsey; Jonathan Z Long; Daniel K Nomura; Laura J Sim-Selley; Benjamin F Cravatt; Hamid I Akbarali; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2011-06-30       Impact factor: 4.030

9.  Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.

Authors:  L L Ferrari; L J Agostinelli; M J Krashes; B B Lowell; T E Scammell; E Arrigoni
Journal:  J Physiol       Date:  2016-01-05       Impact factor: 5.182

Review 10.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.